HealthTell

📍 San Ramon, United States🗓 Founded 2012👥 9 employees💰 Last funded Jan 2013
Biotechnology Research🌐 healthtell.com
Website LinkedIn
HealthTell, Inc. is developing next generation immune profiling assays that broadly characterize the immune system, serving as a platform technology for the biopharmaceutical, search and clinical communities. The technology uses a proprietary immune profiling technology to analyze the immune system’s response against disease – with unprecedented depth and specificity. With applications in drug target discovery, monoclonal antibody characterization, and disease monitoring and therapeutic response, HealthTell will shed new light on important diseases such as autoimmune, cancer, CNS, and infectious disease. HealthTell operates a state-of-the-art high throughput centralized laboratory in San Ramon, CA that supports clients in biopharmaceuticals, and research collaborators.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2012
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in HealthTell?
HealthTell has 2 investors on record on gritt.io, including 2 early-stage backers.
When did HealthTell last raise funding?
The most recent investment in HealthTell recorded on gritt.io was in January 2013.
When was HealthTell founded?
HealthTell was founded in 2012.
What industry is HealthTell in?
HealthTell operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is HealthTell based?
HealthTell is headquartered in San Ramon, United States.